Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +48.81%
#3 Galxe Galxe +41.61%
#4 Infinity Ground Infinity Ground +30.19%
#5 Audiera Audiera +29.99%
#6 Fetch.ai Fetch.ai +26.67%
#7 Derive Derive +25.50%
#8 Wiki Cat Wiki Cat +25.33%
#9 Aria.AI Aria.AI +20.16%
#10 Fuzzybear Fuzzybear +18.58%
Coin of the day
Velas Velas
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$38.41
Marktkapitalisatie
$170.67B
Verandering (1 dag)
1.17%
Verandering (1 jaar)
-49.92%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Healthcare
Marktkapitalisatie
Omzet
meer
Winst
Koersgeschiedenis
P/E-verhouding
P/S-verhouding
P/B-verhouding
Operationele marge
WPA
Aandelsplitsingen
Dividenden
Dividendrendement
Uitstaande aandelen
Koersgeschiedenis voor Novo Nordisk A/S (NVO)
Hoogste slotkoers: $38.35 op 2026-03-01

Laagste slotkoers: $28.10 op 2007-07-01
Koersgeschiedenis van Novo Nordisk A/S van 2007 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 17.70%
2025 -51.54%
2024 1.70%
2023 -23.31%
2022 17.33%
2021 57.90%
2020 22.89%
2019 26.29%
2018 -13.92%
2017 49.77%
2016 -37.97%
2015 26.27%
2014 24.70%
2013 10.84%
2012 43.58%
2011 6.03%
2010 -4.61%
2009 14.74%
2008 -41.68%
2007 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $465.49 -7.78%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $755.73 13.32%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $302.35 54.55%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $99.21 -36.97%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $703.96 16.36%
NL